Skip to main content
. 2016 Mar 16;11(7):767–781. doi: 10.2217/nnm.16.14

Figure 2. . Plasma concentrations of siMad2 (%ID/ml) ± SD versus time (h) in A549-WT (A) and A549-DDP (B) tumor models, after IV injection of NTG and TG nanoparticles at 3 mg/kg equivalent siRNA.

Figure 2. 

n = 5 mice.

*p < 0.05; **p < 0.01; ***p < 0.001 (t-test TG vs NTG).

DDP: Cisplatin; NTG: Nontargeted; SD: Standard deviation; TG: Targeted; WT: Wild-type.